Bovine Respiratory Disease Treatment Market 2020 Exclusivity, Size, Share, Growth, Value, Trends, Segmentations, Top Mergers, and Forecast to 2026

Global Bovine Respiratory Disease (BRD) Treatment Market

Bovine respiratory disease (BRD) is the most common disease that is known to affect the lower respiratory tract of cattle, causing bronchopneumonia, which could also result in death. It is a multi-factorial syndrome that is primarily caused by a viral infection, and is further amplified by stress. The most prominent causes behind BRD include the invasion of bacterial agents, such as pasteurella multocida, haemophilus somnus, mannheimia haemolytica, and viral agents such as infectious bovine rhinotracheitis (IBR), bovine respiratory syncytial virus (BRSV), bovine viral diarrhea (BVD), and parainfluenza type-3 virus (PI-3).

To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/1224

Rising cattle production due to rising demand for animal meat is expected to drive growth of bovine respiratory disease treatment market

According to a study published in the Turkish Journal of Veterinary and Animal Sciences in 2016, bovine respiratory disease (BRD) is the most common disease found in cattle, causing around 75% of morbidity and accounting for over 50% of cattle deaths. The increasing prevalence of BRD among cattle is expected to drive growth of the global bovine respiratory disease treatment market in the near future.

In 2016, the U.S. Department of Agriculture (USDA) reported that cattle production is one of the most important industries in the U.S., which was valued at US$ 78.2 billion in 2015. Rising population, in turn, is increasing the demand for cattle meat and milk products, which further increases the rate of cattle rearing. Increasing cattle rearing inadvertently, increases the prevalence of BRD in cattle. This is expected to create a lucrative environment for the growth of the global bovine respiratory disease treatment market.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://bit.ly/3qRioLZ

Global Bovine Respiratory Disease (BRD) Treatment Market Taxonomy

On the basis of disease type:

• Diphtheria
• Upper Respiratory Tract Infections
• Pneumonia (lower respiratory tract infection)

Based on drug type:

• Antibiotics
• NSAIDs
• Vaccines
• Immunomodulators
• Others

By distribution channel:

• Veterinary Hospitals
• Retail Pharmacies
• Online Pharmacies

Global Bovine Respiratory Disease (BRD) Treatment Market – Geographical Insights

North America is expected to hold a dominant position in the global bovine respiratory disease treatment market, due to the rapidly surging prevalence of the bovine respiratory disease in the region. According to Bovine Respiratory Disease Symposium, 2014, Bovine respiratory disease (BRD) is a worldwide health concern and is very common among cattle in North America. In feedlots, BRD accounts for 70-80% of all feedlot morbidity and 40% to 50% of all mortality, in the U.S. Asia Pacific is expected to show significant growth in bovine respiratory disease market due to increasing rearing of cattle in China. As per an article published by the U.S. Department of Agriculture in 2017, China is the world’s second largest beef meat exporter.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/1224

Global Bovine Respiratory Disease (BRD) Treatment Market – Competititve Backdrop

The key players involved in the global bovine respiratory disease treatment market include Zoetis Inc., Bayer AG, Merck & Co., Inc., Virbac Group, Boehringer Ingelheim GmbH, Elanco, Vetoquinol, and Bimeda Animal Health.

In 2015, Bayer launched Immunostimulant Zelnate, which is known to effectively diminish BRD-associated mortality rates and lung lesions in cattle. For the record, Zelnate is the first cytosine-phosphate-guanine (CpG) motif-based immunostimulant authorized by the U.S. Department of Agriculture.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/bovine-respiratory-disease-treatment-market-1224

Table of Content

Global Bovine Respiratory Disease Treatment Market Research Report
Section 1: Global Bovine Respiratory Disease Treatment Industry Overview
Section 2: Global Economic Impact on Bovine Respiratory Disease Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Bovine Respiratory Disease Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Bovine Respiratory Disease Treatment Market Forecast

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837